Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CVD 908-htrA oral typhoid vaccine: Phase II

Results from an 80-volunteer cross-over trial compared dose levels of

Read the full 102 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE